Peer Review History

Original SubmissionApril 12, 2025
Decision Letter - Yih-Kuen Jan, Editor

Dear Dr. Edgar,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Aug 22 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Yih-Kuen Jan, PhD

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please note that PLOS ONE has specific guidelines on code sharing for submissions in which author-generated code underpins the findings in the manuscript. In these cases, we expect all author-generated code to be made available without restrictions upon publication of the work. Please review our guidelines at https://journals.plos.org/plosone/s/materials-and-software-sharing#loc-sharing-code and ensure that your code is shared in a way that follows best practice and facilitates reproducibility and reuse.

3. In the online submission form, you indicated that [Data cannot be shared publicly because of Ethics approval provisions. Data are available from the SMHS Institutional Data Access / Ethics Committee (contact via SMHS.rgo@health.wa.gov.au) for researchers who meet the criteria for access to confidential data.].

All PLOS journals now require all data underlying the findings described in their manuscript to be freely available to other researchers, either 1. In a public repository, 2. Within the manuscript itself, or 3. Uploaded as supplementary information.

This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If your data cannot be made publicly available for ethical or legal reasons (e.g., public availability would compromise patient privacy), please explain your reasons on resubmission and your exemption request will be escalated for approval.

4. Please include a separate caption for each figure in your manuscript.

5. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information .

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

Reviewer #1: Partly

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #1: No

Reviewer #2: No

**********

3. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: Yes

Reviewer #2: Yes

**********

Reviewer #1: This study evaluates the accuracy of twelve wearable devices in detecting step counts during slow and shuffling walking, simulating hospital conditions. The Apple Watch, particularly when worn on the waist, demonstrated the highest accuracy and consistency across all metrics. The experimental design was rigorous, with standardized gait conditions, manual video-based step counting, and comprehensive testing across arm, waist, and leg placements. The use of healthy participants simulating altered gait is a practical limitation, as it may not fully replicate the complexity of real patient movement. In addition, while the Apple Watch's strengths are emphasized, the reasons behind poor performance of other devices, such as GENEActiv, are less thoroughly examined. The focus on only slow and shuffling gaits also limits the generalizability to broader walking patterns. Nonetheless, the findings have strong clinical relevance. They support using the Apple Watch for activity monitoring in settings with impaired gait, and highlight the importance of body placement for accurate measurement. These insights can inform clinical practice, wearable device design, and algorithm development for more robust patient monitoring.

A few minor issues need to be addressed before publication.

1. Lack of real patient data: Although using healthy participants to simulate slow and shuffling gait is a reasonable starting point, the absence of clinical populations (e.g., elderly or neurologically impaired patients) limits the external validity. Simulated gait may not capture biomechanical and neuromuscular irregularities, such as asymmetrical patterns or compensatory strategies, that influence wearable device performance in actual hospital settings.

2. Underexplored device-specific limitations: The poor performance of devices like GENEActiv and Withings is reported, but not adequately analyzed. A more technical discussion is needed regarding the potential causes—such as accelerometer placement sensitivity, sampling frequency, lack of native step detection algorithms, or preprocessing methods—to provide useful guidance for both researchers and developers.

3. Unclear randomization protocol for device-body placement: The manuscript mentions rotating devices across the arm, waist, and leg, but does not clarify whether a consistent or randomized sequence was used for device positioning across participants. If the order was fixed or unbalanced, it may introduce systematic bias due to fatigue or acclimation effects. Details about the randomization or counterbalancing strategy are necessary to validate the internal control of the experimental design.

4. Insufficient constraint on shuffling gait standardization: The “shuffle walk” condition is described as reduced hip and knee flexion, but no objective control or instrumentation (e.g., motion capture thresholds, wearable inertial measures) was reported to enforce consistency. Since shuffling can vary widely across individuals, lack of constraint may introduce significant variability in motion amplitude and step detection, affecting device comparability and statistical power. More standardized control (e.g., minimum flexion angles or visual feedback) is needed to ensure reproducibility.

5. Statistical modeling of repeated measures: The study includes repeated walking blocks and multiple device placements per participant, yet the manuscript does not specify whether statistical models (e.g., linear mixed models) were used to account for within-subject dependency. Failing to model repeated measures appropriately could inflate type I errors or underestimate variance, affecting interpretation of device performance rankings.

Reviewer #2: Dear Authors,

Your manuscript proposes a hybrid deep learning model combining Stacked LSTM and Random Forest for the early detection of liver cirrhosis using clinical data. This is an important area of research, and your focus on using machine learning for early diagnosis is timely and relevant.

To improve the quality and impact of your work, I offer the following suggestions:

(a) Clarify the rationale for using SLSTM: Please explain why a recurrent architecture is appropriate for this dataset, which appears to be primarily tabular/non-temporal.

(b) Benchmark with additional models: Include comparisons with other machine learning techniques (e.g., XGBoost, Logistic Regression, CNN for tabular data) and/or clinical scores (e.g., MELD or Child-Pugh scores if relevant).

(c) Add statistical rigor: Incorporate cross-validation, report standard deviations, and if possible, include statistical significance testing to support the claims.

(d) Improve interpretability: Include SHAP or similar methods to show which features contribute most to the model’s predictions. Feature importance is shown for Random Forest, but interpretability is not explored (e.g., SHAP, LIME), which is essential for healthcare applications.

(e) Language and formatting: The manuscript would benefit from language polishing and clearer figure/table labeling. For example, figure captions should be more descriptive.

(f) Share processing pipeline: Consider providing your detailed preprocessing steps to enhance transparency and reproducibility.

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #1: No

Reviewer #2: Yes:  Shake Ibna Abir

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.

Revision 1

Please see attached file.

Attachments
Attachment
Submitted filename: wearables_PONE_Response to reviewers_R1_06082025.docx
Decision Letter - Yih-Kuen Jan, Editor

Dear Dr. Edgar,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Oct 12 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Yih-Kuen Jan, PhD

Academic Editor

PLOS ONE

Journal Requirements:

If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. 

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

Reviewer #1: All comments have been addressed

Reviewer #3: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions??>

Reviewer #1: Yes

Reviewer #3: Partly

**********

3. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #1: Yes

Reviewer #3: I Don't Know

**********

4. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy

Reviewer #1: Yes

Reviewer #3: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: Yes

Reviewer #3: Yes

**********

Reviewer #1: The authors have provided a thorough and thoughtful revision of their manuscript, and I thank them for their diligent work in addressing the concerns raised in the initial review. The authors have corrected the major methodological issue concerning the statistical analysis by implementing a linear mixed-effects model to appropriately account for repeated measures. The addition of this robust analysis, including pairwise comparisons and a new Figure 8, has significantly strengthened the validity of the study's conclusions. The manuscript is now a much stronger and more rigorous piece of research. The authors have successfully addressed all my previous concerns.

Reviewer #3: In this study, the authors have investigated the accurate measurement of simulated slow and altered walking activity: Apple Watch best in class wearable devices. The topic of the manuscript is interesting. However, there are some minor concerns that should be addressed before the article can be accepted for publication.

1. Please add more subjects’ information, ex. age, BMI etc.

2. Explain the experimental procedure, for example. Is the order of the walking pattern random? Is the order of wearable devices also random ? Do these subjects know which device brand of device they wear while experiments?

3. Have the authors considered letting these subjects walk at their own speed?

4. Please explain more specifications about the device, for example, manufacture date, tolerance range, and even price. If the devices need to be calibrated, are the settings correct?

5. The resolution of the figures needs to be improved.

6. Part of the title “Apple Watch best in class wearable devices.” It might not be suitable for an academic research article. If it is possible, maybe it needs to be modified.

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #1: Yes:  Pu-Chun Mo

Reviewer #3: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.

Revision 2

Thank you to the reviewers for taking the time to review our revised manuscript - please see extended responses in the attached document.

Attachments
Attachment
Submitted filename: wearables_PONE_Response to reviewers_R2_05092025.docx
Decision Letter - Yih-Kuen Jan, Editor

Accurate measurement of simulated slow and altered walking activity: Apple Watch best in class wearable devices

PONE-D-25-18604R2

Dear Dr. Edgar,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager®  and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support .

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Yih-Kuen Jan, PhD

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

Reviewer #3: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions??>

Reviewer #3: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #3: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy

Reviewer #3: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #3: Yes

**********

Reviewer #3: (No Response)

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #3: No

**********

Formally Accepted
Acceptance Letter - Yih-Kuen Jan, Editor

PONE-D-25-18604R2

PLOS ONE

Dear Dr. Edgar,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Yih-Kuen Jan

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .